We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Tacks on Three Months to PDUFA Date for Analgesic Exparel
FDA Tacks on Three Months to PDUFA Date for Analgesic Exparel
June 14, 2011
The FDA has extended by three months the Prescription Drug User Fee Act (PDUFA) action goal date for Pacira Pharmaceuticals’ analgesic Exparel, pushing its decision to Oct. 28.